| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a10a6e256f4419ad73a8993eed237325 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-557 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92 |
| filingDate |
2001-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d83504deb0dd1881d42d1b77c4be5096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f518e7b3c320ff2d2ff8225824ce0c27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_868e591413858706ded133a25ddd5fa9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6af63bceba3572ecd10f29acdd899d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11052c8bf8f9a2f51246af96db58dd62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4df0dba1d2866b94966129d8e07b801
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c4319404ab0c25fbe634461773e1026 |
| publicationDate |
2016-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2412317-C |
| titleOfInvention |
A method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality |
| abstract |
A method for diagnosing a condition of a patient involves the steps of (a) adding one or more reagents to a test sample from a patient, the test samples comprising at least part of a blood sample from the patient, in order to cause formation of a complex comprising at least one acute phase protein at at least one human lipoprotein, while causing substantially no fiber polymerization; (b) measuring the formation of the complex over time so as to derive a time-dependent measurement profile, and (c) determining a slope and/or total change in the time-dependent measurement profile, so as to diagnose a condition of the patient. A greater formation of the complex is correlated to increased probability of death of the patient. |
| priorityDate |
2000-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |